← Leaderboards
Ronald D Wiehle
Zonagen, Inc.
$1,443,660
Attributed
$1,443,660
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,443,660 · 5
By mechanism
R44$836,441 · 1
P51$384,683 · 2
R43$222,536 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Progestins”
- Christina Wang · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$15,918,137
- Howard N Hodis · University Of Southern California$13,927,861
- Andrew G Herzog · Beth Israel Deaconess Medical Center$10,510,436
- William Bremner · University Of Washington$9,149,758
- Gunda I. Georg · University Of Kansas Lawrence$8,258,859
- Charles Robert Wira · Dartmouth College$7,400,660
Research focus
ProgestinsMifepristoneDrug Screening /EvaluationHormone InhibitorEndometriosisDrug Design /Synthesis /ProductionMacaca FascicularisReproductive System PharmacologyEndometriumHistologyHormone MetabolismPeritoneal FluidReproductive System Disorder ChemotherapyBone DensityAntineoplasticsInhibitor /AntagonistLaboratory RatBreast NeoplasmsNeoplastic GrowthEndocrinologyDosageAnimal ColonyEstrogen ReceptorsClinical Research
Grant awards (6)
ANTIPROGESTINS IN CYNOMOLGUS ENDOMETRIOSIS$57,407
P51 · FY2004 · RR
ANTIPROGESTINS IN CYNOMOLGUS ENDOMETRIOSIS$327,276
P51 · FY2003 · RR
Antiprogestins in Cynomolgus Endometriosis$26,644
R44 · FY2003 · HD
Antiprogestins in Cynomolgus Endometriosis$809,797
R44 · FY2002 · HD
Breast Tumor Inhibition by Antiprogestins$108,351
R43 · FY2002 · CA
ANTIPROGESTINS IN ENDOMETRIUM$114,185
R43 · FY2000 · HD